Cite

HARVARD Citation

    Dutertre, M. et al. (2019). Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab. European journal of cancer. pp. 21-23. [Online]. 
  
Back to record